Table 1.
Baseline characteristics of patients with coronary artery disease in the AtheroGene study according to occurrence of cardiovascular event (cardiovascular death or non-fatal myocardial infarction) during follow-up
| Cardiovascular event | |||
|---|---|---|---|
| No (n = 1,039) | Yes (n = 235) | p value | |
| Age, years | 61.0 (0.3) | 63.8 (0.6) | <0.0001 |
| Females, % | 25.1 | 25.5 | 0.90 |
| Body mass index | 27.2 (0.1) | 27.3 (0.2) | 0.68 |
| Current smoker, % | 12.3 | 16.6 | 0.08 |
| Diabetes, % | 14.6 | 22.1 | 0.005 |
| Hypertension, % | 72.6 | 74.0 | 0.65 |
| Statin, % | 36.5 | 29.4 | 0.04 |
| Beta-blocker, % | 59.9 | 54.5 | 0.13 |
| Angiotensin-converting enzyme inhibitors, % | 45.9 | 53.2 | 0.04 |
| Total cholesterol, mg/dL | 220.9 (1.4) | 214.5 (2.9) | 0.05 |
| LDL cholesterol, mg/dL | 141.6 (1.2) | 138.3 (2.6) | 0.27 |
| HDL cholesterol, mg/dL | 49.0 (0.4) | 45.1 (0.9) | 0.0002 |
| Triglyceride, mg/dLa | 167.8 (3.2) | 172.7 (6.9) | 0.15 |
| Fibrinogen, mg/dLa | 354.2 (3.8) | 386.1 (8.0) | 0.0002 |
| hs-CRP, mg/La | 13.8 (1.0) | 19.5 (2.1) | 0.01 |
Categorical variables are presented as percentages; continuous variables are presented as age- and sex-adjusted mean (SEM)
aTest performed on log-transformed variable